Regorafenib

Regorafenib; C3604; 1 mg

P/N	ALC-C3604-01

68,00 €

excl. VAT (19%), plus shipping

Add to cart

Add to List

Compare

Questions?

Email a friend

Description

Regorafenib is intended for Cancer applications. All information about Regorafenib is provided in the MSDS. All compounds are delivered with high purity levels and a comprehensive Certificate of Analysis.

Features

Content	1 mg
Isotop Labeled	No
Substance Group	Cancer
Compound Name	Regorafenib

Reviews

Be the first to review this item

There are no reviews yet

Description

Features

Reviews

Recently viewed products

Ceftaroline ditrifluoroacetate salt

[13C2, 2H3]-Vaborbactam